Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 394.44 K332.26 K317.52 K262.05 K 1.31 M Research & development ———— — Operating income 331.73 K362.7 K91.47 K484.81 K 1.27 M Non-Operating Income, Total 13.46 K19.05 K22.88 K358.68 K 414.06 K Interest expense, net of interest capitalized 1 0751 0811 0751 148 4 379 Non-Operating Income, excl. Interest Expenses 12.38 K17.96 K21.8 K357.54 K 409.69 K Unusual income/expense ———— — Pretax income 345.18 K381.74 K114.35 K843.49 K 1.68 M Equity in earnings ———— — Taxes 103.23 K58.23 K64.11 K153.47 K 379.04 K Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 241.95 K323.51 K50.24 K690.02 K 1.31 M Discontinued operations ———— — Net income 241.95 K323.51 K50.24 K690.02 K 1.31 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 241.95 K323.51 K50.24 K690.02 K 1.31 M Basic earnings per share (Basic EPS) 0.120.160.020.34 0.64 Diluted earnings per share (Diluted EPS) 0.120.160.020.33 0.63 Average basic shares outstanding 2.05 M2.05 M2.05 M2.05 M — Diluted shares outstanding 2.07 M2.08 M2.08 M2.08 M — EBITDA 1.01 M1.03 M755.74 K1.01 M 3.79 M EBIT 331.73 K362.7 K91.47 K484.81 K 1.27 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 675.27 K662.65 K664.27 K521.64 K 2.52 M